|
|
Can publicly traded US biotech/pharmaceutical companies maintain a strong financial performance while improving their ESG score? |
|---|---|
| Author: | Detilloux, Sébastien1 |
| Organizations: |
1University of Oulu, Oulu Business School, Department of Finance, Finance |
| Format: | ebook |
| Version: | published version |
| Access: | restricted |
| Theses with restricted access are only available for reading on the e-thesis workstations. | |
| Pages: | 85 |
| Persistent link: | http://urn.fi/URN:NBN:fi:oulu-202306152507 |
| Language: | English |
| Published: |
Oulu : S. Detilloux,
2023
|
| Publish Date: | 2023-06-15 |
| Thesis type: | Master's thesis |
| Tutor: |
Ruman, Asif |
| Reviewer: |
Ruman, Asif Sahlström, Petri |
| Subjects: | |
| Copyright information: |
© Sébastien Detilloux, 2023. This publication is copyrighted. You may download, display and print it for your own personal use. Commercial use is prohibited. |